Investments
A Deliberate Process
At Mayview Capital, capital deployment is a deliberate, long-term process. Our capital is structured to support, accelerate, and protect value across complex market cycles. It is this long-term horizon that allows Mayview Capital to build strong, resilient businesses alongside partners who value sustainability and operational excellence.
Real Estate
Mayview Capital actively targets high-quality commercial assets, prime residential regeneration, and value-add developments. Our focus is concentrated in London and select global gateway cities where we can leverage deep structural knowledge.
Private Equity & Growth
We deploy strategic capital into established mid-market enterprises. Mayview Capital supports leadership teams in optimising operations, scaling regional footprints, and driving sustainable enterprise value.
Venture & Sustainability
Backing early and growth-stage platforms that address critical shifts in energy transition, resource efficiency, and agricultural technology. Mayview Capital focuses on companies with clear paths to commercial viability.
trogenix.com
A pioneering genetic medicine platform spun out from the University of Edinburgh. Backed alongside IQ Capital, 4BIO Capital, and Eli Lilly, Trogenix is advancing its Odysseus® platform to bring potentially curative, one-dose gene therapies for aggressive solid tumors into human clinical trials.
bioorbit.com
A space-biotech platform leveraging the microgravity environment of space stations to reformulate complex cancer immunotherapies.
loxacover.com
Loxa is a UK-based embedded insurance company that helps retailers offer product protection at the point of sale, including online and in-store.
aisot.com
Aisot Technologies is a Zurich-based AI company and ETH Zurich spin-off that builds AI-driven investment and portfolio-intelligence tools for asset managers, financial advisors, brokers, and family offices